CT
IBB icon

Colonial Trust’s iShares Biotechnology ETF IBB Stock Holding History

Colonial Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Sell
8,302
-500
-6% -$85.9K 0.2% 108
2026
Q1 		$1.49M Sell
8,802
-200
-2% -$34.2K 0.2% 107
2025
Q4 		$1.52M Sell
9,002
-860
-9% -$140K 0.2% 104
2025
Q3 		$1.42M Sell
9,862
-114
-1% -$15.6K 0.19% 109
2025
Q2 		$1.26M Sell
9,976
-657
-6% -$80.7K 0.18% 110
2025
Q1 		$1.36M Sell
10,633
-271
-2% -$36.7K 0.21% 102
2024
Q4 		$1.44M Buy
10,904
+645
+6% +$90.7K 0.21% 97
2024
Q3 		$1.49M Sell
10,259
-608
-6% -$88K 0.23% 96
2024
Q2 		$1.49M Sell
10,867
-139
-1% -$18.6K 0.26% 86
2024
Q1 		$1.51M Sell
11,006
-361
-3% -$49.3K 0.28% 83
2023
Q4 		$1.54M Sell
11,367
-343
-3% -$41.8K 0.32% 77
2023
Q3 		$1.43M Sell
11,710
-733
-6% -$93.2K 0.35% 71
2023
Q2 		$1.58M Buy
12,443
+80
+0.6% +$10.4K 0.38% 69
2023
Q1 		$1.6M Sell
12,363
-202
-2% -$26.4K 0.41% 66
2022
Q4 		$1.65M Buy
12,565
+415
+3% +$53.6K 0.45% 63
2022
Q3 		$1.42M Buy
+12,150
New +$1.51M 0.45% 64

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Colonial Trust's IBB Position: Q2 2026 in Review

Colonial Trust reduced its iShares Biotechnology ETF (IBB) stake by 5.7% in Q2 2026, selling an estimated $85.9K and leaving 8,302 shares worth $1.58M. The position accounts for 0.2% of the portfolio, ranked #108.

Colonial Trust first reported a position in IBB in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.65M in Q4 2022. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Colonial Trust held 8,302 shares of iShares Biotechnology ETF worth $1.58M as of Q2 2026.
  • Colonial Trust sold 500 iShares Biotechnology ETF shares in Q2 2026, an estimated $85.9K.
  • iShares Biotechnology ETF made up 0.2% of Colonial Trust's portfolio in Q2 2026, its #108 holding.
  • Colonial Trust first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 16 quarters since.
  • Colonial Trust's iShares Biotechnology ETF position peaked at $1.65M in Q4 2022.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.